High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice

Blood

Volumn 90, Issue 11, 1997, Pages 4369-4383

  Villeval, Jean Luc ^a   Cohen Solal, Karine ^b   Tulliez, Micheline ^b   Giraudier, Stéphane ^b   Guichard, Josette ^b   Burstein, Samuel A ^b   Cramer, Elisabeth M ^b   Vainchenker, William ^b   Wendling, Françoise ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT; DISEASE ASSOCIATION; FIBROSIS; GENETIC TRANSDUCTION; HUMAN; HYPOPLASIA; MOUSE; MYELOPROLIFERATIVE DISORDER; OSTEOSCLEROSIS; PANCYTOPENIA; PERITONEAL CAVITY; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0030718597     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4369     Document Type: Article

References (54)

1. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Fostrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopoietin and stimulation of platelet production in vivo. Nature 369:565, 1994
2. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg LAJ, Goeddl DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-MPL ligand. Nature 369:533, 1994
3. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliot G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu M-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
4. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Fostrum JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568, 1994
5. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571, 1994
6. Sohma Y, Akahori H, Seki N, Hori TA, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H: Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Letts 353:57, 1994
7. Kuter DJ, Beeler DL, Rosenberg RD: The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 91:11104, 1994
8. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M: Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89:5640, 1992
9. Vigon I, Florindo C, Fichelson S, Guenet JL, Mattei MG, Souyri M, Cosman D, Gisselbrecht S: Characterization of the murine Mpl protooncogene, a member of the hematopoietic cytokine receptor family: Molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 8:2607, 1993
10. Skoda RC, Seldin DC, Chiang M-K, Peichel CL, Vogt TF, Leder P: Murine c-mpl: A member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J 12:2645, 1993
11. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 86:419, 1995
12. Sitnicka E, Lin N, Priestly GV, Fox N, Broudy VC, Wolf NS, Kaushansky K: The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87:4996, 1996
13. Ku H, Yonemura Y, Kaushansky K, Ogawa M: Thrombopoietin, the ligand for the MPL receptor, synergizes with Steel Factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors in mice. Blood 87:4544, 1996
14. Petzer AL, Zandstra PW, Piret JM, Eaves CJ: Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: Novel responses to flt3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
15. Young JC, Bruno E, Luens KM, Wu S, Backer M, Murray LJ: Thrombopoietin stimulates megakaryopoiesis, myelopoiesis and expansion of CD34+ progenitor cells from single CD34+ Thy-1 + Lin- primitive progenitor cells. Blood 88:1619, 1996
16. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Recombinant human thrombopoietin (MPL ligand) enhances proliferation of erythroid progenitors. Blood 86:2494, 1995
17. Papayannopoulou T, Brice M, Farrer D, Kaushansky K: Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy. Exp Hematol 24:660, 1996
18. Harker LA, Hunt P, Marzec UM, Kelly AB, Tomer A, Hanson SR, Stead RB: Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 87:1833, 1996
19. Farese AM, Hunt P, Boone T, MacVittie TJ: Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 86:54, 1995
20. O'Malley CJ, Rasko JEJ, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG; Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 88:3288, 1996
21. Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel KH, Broudy VC: Thrombopoietin expands erythroid, granulocyte-macro-phage, and megakaryocytic progenitor cells in normal and myelosuppressive therapy. Exp Hematol 24:265, 1996
22. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D: Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87:2162, 1996
23. Carver-Moore K, Broxmeyer HE, Luoh S-M, Cooper S, Peng J, Burstein SA, Moore MW, de Sauvage FJ: Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood 88:803, 1996
24. Kaushansky K, Broudy VC, Grossmann A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou T, Forstrom JW, Sprugel KH: Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 96:1683, 1995
25. Grossmann A, Lenox J, Ren HP, Humes JM, Forstrom JW, Kaushansky K, Sprugel KH: Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol 24:1238, 1996
26. Ohwada A, Rafii S, Moore MAS, Crystal RG: In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 88:778, 1996
27. Ulich TR, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shuffer J, Bogenberger J, Sun D, Samat B, Shimamoto G, Lee R, Steinbrink R, Boone T, Sheridan WT, Hunt P: Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 86:971, 1995
28. De Gabriele G, Penington DG: Regulation of platelet production: "Thrombopoietin." Br J Haematol 13:210, 1967
29. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K: Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86:3668, 1995
30. Stoffel R, Wiestner A, Skoda RC: Thrombopoietin in thrombocytopenic mice: Evidence against regulation of the mRNA level and for a direct regulatory role of platelets. Blood 87:567, 1996
31. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87:2154, 1996
32. Cohen-Solal K, Villeval JL, Titeux M, Lok S, Vainchenker W, Wendling F: Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 88:2578, 1996
33. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJM, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695, 1995
34. Hornkohl A, Selesi D, Bennett L, Hockman H, Nichol J, Hunt P: Thrombopoietin and sMPL concentrations in the serum and plasma of normal donors. Blood 86:898a, 1995 (abstr)
35. Matsumura I, Kanakura Y, Ikeda H, Ishikawa J, Yoshida H, Horikawa Y, Nishiura T, Tahara T, Kato T, Miyazaki H, Matsuzawa Y: Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Leukemia 10:91, 1996
36. Sasaki A, Katoh O, Kawaishi K, Hyodo H, Kimura A, Satow Y, Kuramoto A: Expression of c-Mpl and c-Mpl ligand gene in hematopoietic cells of individuals with and without myeloproliferative disorders and leukemia cell lines. Int J Hematol 62:217, 1995
37. Schrezenmeier H, Griesshammer M, Hornkohl A, Nichol JL, Hecht T, Kubanek B, Herrmann F: Elevated endogenous thrombopoietin (TPO) levels in sera of patients with essential thrombocythemia (ET): TPO overproduction as a cause of thrombocytosis? Exp Hematol 24:570, 1996 (abstr)
38. Yan X-Q, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y, Xla M, Mu S, Saris C, Hill D, Hawley RG, McNiece IK: Chronic exposure to retroviral encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86:4025, 1995
39. Yan X-Q, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK: A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation. Blood 88:402, 1996
40. Johnson GR, Gonda TJ, Metcalf D, Hariharan IK, Cory S: A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J 8:441, 1989
41. Markowitz D, Goff S, Bank A: A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J Virol 62:1120, 1988
42. Adra CN, Boer PH, McBurney MW: Cloning and expression of the mouse pgk-l gene and the nucleotide sequence of its promoter. Gene 60:65, 1987
43. Villeval J-L, Metcalf D, Johnson GR: Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells. Leukemia 6:107, 1992
44. Metcalf D: The Hemopoietic Colony-Stimulating Factors. New York, NY, Elsevier, 1984
45. Gough NM, Metcalf D, Gough J, Grail D, Dunn AR: Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor. EMBO J 4:645, 1985
46. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156, 1987
47. Chang MS, McNinch J, Basu R, Shutter J, Hsu RY, Perkins C, Mar V, Suggs S, Welcher A, Li L, Lu H, Bartley T, Hunt P, Martin F, Samal B, Bogenberger J: Cloning and characterization of The human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 270:511, 1995
48. Frey BM, Cannizo S, Crystal RG, Moore MAS: Expression of human thrombopoietin transgene delivered by an adenovirus based strategy is dependent on host immune competence. Exp Hematol 24:177, 1996 (abstr)
49. Ulich TR, del Castillo J, Senaldi G, Kinstler O, Yin S, Kaufman S, Tarpley J, Choi E, Kirley T, Hunt P, Sheridan WP: Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood 87:5006, 1996
50. Zhou W, Toombs CF, Zou T, Guo J, Robinson MO: Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 89:1551, 1997
51. Ward H, Block M: The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore) 50:357, 1971
52. Reilly J: Pathogenesis of idiopathic myelofibrosis: Present status and future directions. Br J Haematol 88:1, 1994
53. Bouroncle BA, Doan CA: Myelofibrosis clinical hematologic and pathologic study of 110 patients. Am J Med Sci 57:697, 1962
54. Hawley R, Fong A, Ngan B, de LV, Clark S, Hawley T: Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras. J Exp Med 178:1175, 1993